[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.106.138. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
February 20, 2002

Pharmaceutical Representatives and Resident Physicians

Author Affiliations
 

Stephen J.LurieMD, PhDIndividualAuthor

JAMA. 2002;287(7):844. doi:10.1001/jama.287.7.839

To the Editor: Dr McCormick and colleagues1 found that residents' attitudes and behavior were influenced by the amount of their exposure to pharmaceutical company representatives. As a resident in a program that has a long commitment to independence from pharmaceutical representatives, I support the authors' conclusions.

When patients ask me about the availability of complimentary samples at our practice, I am proud to tell them of our policy barring pharmaceutical representatives. We in the medical profession have primarily our integrity to offer patients; without our patients' trust how can we expect them to follow our advice for treatment or even to forgive us our human mistakes? When I explain to my patients that my recommendations to them are based on studies published with disclosure in journals and not on my gratitude for a "drug lunch," they rarely complain about our lack of free medication.

First Page Preview View Large
First page PDF preview
First page PDF preview
×